On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the “maximum fair prices (MFPs)” for the first 10 drugs subject to the Medicare drug negotiation program. 

The Centers for Medicare & Medicaid Services (CMS) released the Part D national average bid amount and Part D base beneficiary premiums for 2025.

The Centers for Medicare & Medicaid Services (CMS) released its annual proposed rule updating the Medicare Physician Fee Schedule (MPFS) for calendar year (CY) 2025.

The Centers for Medicare & Medicaid Services (CMS) finalized the second part of its guidance on implementation of the IRA’s Medicare Prescription Payment Plan (MPPP), known informally as Part D monthly out of-pocket “smoothing”.

Adam Finkelstein was quoted in a Modern Healthcare article about value-based care VBC innovation goals set by Congress and CMS.

Adam Finkelstein spoke with FierceHealthcare about the trends that are driving Medicare Advantage enrollment.

Manatt provided corporate and regulatory counsel to startup Medicare Advantage health plans Astiva Health, Inc., and Brandman Health Plan, Inc., as they obtained the financing, Knox-Keene licenses and Centers for Medicaid & Medicare Services contracts.

Adam Finkelstein spoke with Modern Healthcare about the administration’s recent executive order, which called on the HHS secretary to create rules to tie Medicare outpatient drug payment to international prices.